S216: CLINICAL ACTIVITY OF CC-99282, A CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA (R/R NHL) – RESULTS FROM A PHASE 1, OPEN-LABEL STUDY

• J.-M. Michot,
• J. C. Chavez,
• C Carpio,
• S. Ferrari,
• T. A. Feldman,
• D. Morillo,
• J. Kuruvilla,
• A. Pinto,
• V. Ribrag,
• E Bachy,
• T. J. Buchholz,
• S. Carrancio,
• W.-C. Chou,
• C. Guarinos,
• F. Wu,
• S. Li,
• P. Patah,
• M. Pourdehnad,
• L. Nastoupil

Affiliations

J.-M. Michot

1 Département d’Innovation Thérapeutique et d’Essais Précoces (DITEP), Gustave Roussy Institute of Cancer, Villejuif, France

J. C. Chavez

2 Department of Malignant Hematology, Moffitt Cancer Center, University of South Florida, Tampa, United States of America

C Carpio

3 Department of Hematology, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Autonomous University of Barcelona (UAB), Barcelona, Spain

S. Ferrari

4 Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy

T. A. Feldman

5 Lymphoma Division, John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, United States of America

D. Morillo

6 Department of Hematology, University Hospital Fundación Jiménez Díaz, Madrid, Spain

J. Kuruvilla

7 Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada

A. Pinto

8 Hematology-Oncology & Stem Cell Transplantation Unit, National Cancer Institute, Fondazione G. Pascale, IRCCS, Naples, Italy

V. Ribrag

1 Département d’Innovation Thérapeutique et d’Essais Précoces (DITEP), Gustave Roussy Institute of Cancer, Villejuif, France

E Bachy

9 Department of Hematology, Hospices Civils de Lyon, Lyon, France

T. J. Buchholz

10 Early Clinical Development, Oncology, Bristol Myers Squibb, San Francisco

S. Carrancio

11 Oncogenesis (ONC) Thematic Research Center (TRC), Bristol Myers Squibb, San Diego

W.-C. Chou

12 Early Development Predictive Sciences, Bristol Myers Squibb, Cambridge, United States of America

C. Guarinos

13 ONC TRC-Celgene Institute for Translational Research Europe (CITRE), Bristol Myers Squibb, Seville, Spain

F. Wu

14 Clinical Pharmacology & Pharmacometrics, Bristol Myers Squibb, Summit

S. Li

15 Global Biometric Sciences, Bristol Myers Squibb, Berkley Heights

P. Patah

16 Early Clinical Development, Bristol Myers Squibb, Lawrenceville

M. Pourdehnad

17 Early Clinical Development, Hematology/Oncology and Cell Therapy, Bristol Myers Squibb, San Francisco

L. Nastoupil

18 Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, United States of America